David Lawrence
Angel Investor @ Artiman Ventures
Oakland, United States
David Lawrence is a Series A investor at Artiman Ventures in Oakland focused on Health Care and Biotechnology. David M. Lawrence is a general partner in Conduit Venture Partners, and senior advisor to Burrill and Company, Health Evolution Partners, and Physic Ventures. Previously, he was the CEO of Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals, and chairman of the board from 1992 until his retirement in 2002. David Lawrence serveson the boards of Agilent Technologies, McKesson Corporation, Dynavax Technologies, Raffles Medical Group (Singapore), and Proventys, Inc. and is a special advisor to the board of SomaLogic, Inc., and to the founders of MedExpert, Inc..A member of the RAND Health Advisory Board and the Advisory Board for the RAND COMPARE study on national health reform, David Lawrence is also a founding member of the Lucien Leape Institute of the National Patient Safety Foundation, and the author of From Chaos to Care: The Promise of Team-Based Medicine (Perseus Press, 2002).David Lawrence received his B.A. from Amherst College, his M.D. from the University of Kentucky, and an M.P.H. from the University of Washington. He is board certified in general preventive medicine (Johns Hopkins and University of Washington), a member of Alpha Omega Alpha (Medical Honorary Society) and the Institute of Medicine (National Academy of Sciences), and was named Distinguished Advisor to the National Patient Safety Foundation in 2005.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries David Lawrence invests in
Stages David Lawrence invests in
Countries David Lawrence invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CellMax Life is a biotechnology company that is revolutionizing early cancer detection and prevention. The company’s product portfolio includes a blood test that can detect cancer before it is too late.CellMax Life was founded in 2013 and is based in California, United States. The company has offices in Silicon Valley (U.S.) and Taiwan, andis funded by a venture capital firm in the U.S. and technology industrialists in Taiwan. | $9M / Series A / Jul 26, 2016 |
About Artiman Ventures
Artiman is an early-stage venture fund that seeks to invest in entrepreneurs that have the potential to disrupt multi-billion markets. The firm was established in 2000 and is headquartered in Palo Alto, California, United States.
Artiman Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ajit Singh
Partner
|
|||
Amit Shah
Founder & Partner
|
|||
Ramesh Radhakrishnan
Partner & Managing Director
|
|||
Brian Wilcove
Partner
|
|||
Mahmood Panjwani
Entrepreneur in Residence
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does David Lawrence invest in?
David Lawrence invests primarily in Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact David Lawrence?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did David Lawrence last invest?
The most recent investment recorded for David Lawrence closed in Jul 2016. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
